In the UK, the 2009 Pharmaceutical Price Regulation Scheme (PPRS) settlement included a proposal by the Association of the British Pharmaceutical Industry (ABPI) for the introduction of generic ...

Changing the prescribing behaviors of physicians in the United States with regard to CV drugs alone could save Medicare more than $600 million a year, an analysis shows. “Despite focus on this issue ...

Generic medicines, which are clinically equivalent to their branded counterparts, are a cornerstone in efforts to improve healthcare affordability and broaden patient access to essential treatments.

Please provide your email address to receive an email when new articles are posted on . A study published in Circulation: Cardiovascular Quality and Outcomes found that substituting generic CV ...

A new study published in the American Journal of Transplantation reveals that substitution of a brand name immunosuppressive drug with a generic (manufactured by Sandoz) for preventing rejection of ...

Generic drug substitution can markedly decrease the cost of health care. For conditions where agents have a relatively narrow therapeutic index, notably epilepsy, financial savings through generic ...

Please provide your email address to receive an email when new articles are posted on . While the generic drug market steadily grows in Europe, and generic substitution has become the rule in all ...

December 5, 2006 (San Diego) -- Mandatory generic substitution of antiepileptic drugs (AEDs) is raising concerns among physicians and patients that this increasingly common practice is causing a rise ...

Over the last couple years, there have been several major instances of popular generics failing to prove bioequivalent to the brand name they’re based on. Blockbuster brand-name drugs may make the ...

A new study adds weight to the argument that, for some epilepsy medications, generic drugs should not be substituted for brand-name drugs, at least not without informing the patient and physician. ST.

Prescription drug brand names no longer function as trademarks. They have become the common names of generic versions of the medicine. As a result of state substitution laws, most prescriptions are ...

Only eight states have enacted laws but legislation is pending in many more. Biosimilar products have not yet reached the U.S. market, but debates on the laws and regulations that will govern them ...